Tag: Reneo Pharmaceuticals Inc.

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Reneo Pharmaceuticals

Analysts Viewpoint

Reneo Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Leonard Braden Michael acquired Company’s shares for reported $75108.0 on

Analysts Viewpoint

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Reneo Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Leonard Braden Michael acquired Company’s shares for reported $0.24 million